Companies / Santa Cruz Biotechnology / α-synuclein (211) PE
Santa Cruz Biotechnology

α-synuclein (211) PE | Santa Cruz Biotechnology

mouse monoclonal IgG1; α-synuclein Antibody (211) is an IgG1 κ mouse monoclonal alpha-synuclein antibody (also designated SNCA antibody, synuclein antibody or alpha synuclein antibody) that detects the alpha-synuclein protein of human origin by WB, IP, IF and IHC(P). α-synuclein Antibody (211) is available as both the non-conjugated anti-alpha-synuclein antibody form, as well as multiple conjugated forms of anti-alpha-synuclein antibody, including agarose, HRP, PE, FITC and multiple Alexa Fluor® conjugates. The synuclein family members, including α-synuclein (also designated NACP for non-β-Amyloid component) and β-synuclein, are predominantly expressed in the brain and are speculated to be involved in synaptic regulation and neuronal plasticity. α-synuclein is localized to neuronal cell bodies and synapses. α-synuclein was first identified as a component of Alzheimer's disease amyloid plaques. Abnormal platelet function in Alzheimer's disease has been demonstrated. During megakaryocytic differentiation α-synuclein has been found to be upregulated, while β-synuclein is downregulated, indicating that coordinate expression of synucleins may be important during hematopoetic cell differentiation. A mutant form of α-synuclein has been found in patients with early onset Parkinson's disease.

Reviews


No reviews yet

ABOUT THE COMPANY

Santa Cruz Biotechnology is a world leader in the development of products for the biomedical research market. Over the past 30+ years, the Company has focused on the ongoing development of research antibodies, siRNA and CRISPR Gene editing tools, biochemicals, labware and more recently has expanded into animal health care products. Santa Cruz Biotechnology has the highest commitment to quality and customer service.